These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

808 related items for PubMed ID: 24366000

  • 1. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
    Shimizu D, Kanda M, Nomoto S, Oya H, Takami H, Hibino S, Suenaga M, Inokawa Y, Hishida M, Takano N, Nishikawa Y, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y.
    Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of expression and epigenetic profiling of TUSC1 in gastric cancer.
    Kanda M, Shimizu D, Nomoto S, Hibino S, Oya H, Takami H, Kobayashi D, Yamada S, Inokawa Y, Tanaka C, Fujii T, Sugimoto H, Koike M, Fujiwara M, Kodera Y.
    J Surg Oncol; 2014 Aug; 110(2):136-44. PubMed ID: 24700496
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of DENND2D by promoter hypermethylation is associated with early recurrence of hepatocellular carcinoma.
    Kanda M, Nomoto S, Oya H, Takami H, Hibino S, Hishida M, Suenaga M, Yamada S, Inokawa Y, Nishikawa Y, Asai M, Fujii T, Sugimoto H, Kodera Y.
    Int J Oncol; 2014 Jan; 44(1):44-52. PubMed ID: 24189587
    [Abstract] [Full Text] [Related]

  • 4. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z.
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [Abstract] [Full Text] [Related]

  • 5. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
    Hayashi M, Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Yamada S, Fujii T, Sugimoto H, Takeda S, Kodera Y.
    J Surg Oncol; 2012 Mar 15; 105(4):381-6. PubMed ID: 22052684
    [Abstract] [Full Text] [Related]

  • 6. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A.
    Ann Surg Oncol; 2010 Mar 15; 17(3):923-32. PubMed ID: 19898900
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z, Zhang H, Yang J, Hao T, Li S.
    Cell Biol Int; 2012 May 01; 36(5):427-32. PubMed ID: 21864295
    [Abstract] [Full Text] [Related]

  • 12. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y.
    Clin Cancer Res; 2008 Nov 15; 14(22):7405-12. PubMed ID: 19010857
    [Abstract] [Full Text] [Related]

  • 13. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY, Hsieh SY, Lu YJ, Wu CS, Chen LC, Lo SJ, Wu CT, Chou MY, Huang TH, Chang YS.
    Genes Chromosomes Cancer; 2009 Dec 15; 48(12):1057-68. PubMed ID: 19760608
    [Abstract] [Full Text] [Related]

  • 14. Quantitative analysis of RASSF1A promoter methylation in hepatocellular carcinoma and its prognostic implications.
    Xu B, Di J, Wang Z, Han X, Li Z, Luo X, Zheng Q.
    Biochem Biophys Res Commun; 2013 Aug 23; 438(2):324-8. PubMed ID: 23891693
    [Abstract] [Full Text] [Related]

  • 15. Clinical utility of PDSS2 expression to stratify patients at risk for recurrence of hepatocellular carcinoma.
    Kanda M, Sugimoto H, Nomoto S, Oya H, Shimizu D, Takami H, Hashimoto R, Sonohara F, Okamura Y, Yamada S, Fujii T, Nakayama G, Koike M, Fujiwara M, Kodera Y.
    Int J Oncol; 2014 Nov 23; 45(5):2005-12. PubMed ID: 25189544
    [Abstract] [Full Text] [Related]

  • 16. Epigenetic silencing of Klotho expression correlates with poor prognosis of human hepatocellular carcinoma.
    Xie B, Zhou J, Yuan L, Ren F, Liu DC, Li Q, Shu G.
    Hum Pathol; 2013 May 23; 44(5):795-801. PubMed ID: 23123137
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of CENP-H as a novel prognostic biomarker for human hepatocellular carcinoma progression and patient survival.
    Lu G, Shan T, He S, Ren M, Zhu M, Hu Y, Lu X, Zhang D.
    Oncol Rep; 2013 Nov 23; 30(5):2238-44. PubMed ID: 23970101
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X, Hu ZP, Li Z, Gao PJ, Zhu JY.
    World J Gastroenterol; 2015 Jul 28; 21(28):8588-604. PubMed ID: 26229401
    [Abstract] [Full Text] [Related]

  • 19. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
    Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Imai K.
    Oncogene; 2000 Nov 02; 19(46):5298-302. PubMed ID: 11077447
    [Abstract] [Full Text] [Related]

  • 20. Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.
    Dai B, Ruan B, Wu J, Wang J, Shang R, Sun W, Li X, Dou K, Wang D, Li Y.
    Int J Clin Exp Pathol; 2014 Nov 02; 7(9):5645-54. PubMed ID: 25337205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.